Cite
Second Affiliated Hospital of Zhejiang University School of Medicine Researchers Update Knowledge of Phosphoric Diester Hydrolases (DOT1L protects against podocyte injury in diabetic kidney disease through phospholipase C-like 1).
MLA
“Second Affiliated Hospital of Zhejiang University School of Medicine Researchers Update Knowledge of Phosphoric Diester Hydrolases (DOT1L Protects against Podocyte Injury in Diabetic Kidney Disease through Phospholipase C-like 1).” Gene Therapy Weekly, Nov. 2024, p. 392. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=180747607&authtype=sso&custid=ns315887.
APA
Second Affiliated Hospital of Zhejiang University School of Medicine Researchers Update Knowledge of Phosphoric Diester Hydrolases (DOT1L protects against podocyte injury in diabetic kidney disease through phospholipase C-like 1). (2024). Gene Therapy Weekly, 392.
Chicago
“Second Affiliated Hospital of Zhejiang University School of Medicine Researchers Update Knowledge of Phosphoric Diester Hydrolases (DOT1L Protects against Podocyte Injury in Diabetic Kidney Disease through Phospholipase C-like 1).” 2024. Gene Therapy Weekly, November, 392. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=180747607&authtype=sso&custid=ns315887.